Literature DB >> 21593038

Empirical model estimation of relative biological effectiveness for proton beam therapy.

Y Chen1, S Ahmad.   

Abstract

A simple model for proton relative biological effectiveness (RBE) is proposed. It describes the RBE as a function of proton depth, the dose and the linear energy transfer (LET) when proton passes through tissue-like materials. Radiobiological parameters were first obtained by fitting the published experimental cell survival data. The dose-averaged LET values were calculated for 250-MeV proton beam in a water phantom by using GEANT4 Monte Carlo simulation code and were then used as input values to calculate the values of RBE as function of depths. The model was also applied to proton spread-out Bragg peak, where the increasing RBE with depth causes an extended RBE-weighted dose in the distal fall-off region. This model was found to be able to reproduce the measured RBE values as a function of LET, depth and dose for a specific cell line.

Mesh:

Substances:

Year:  2011        PMID: 21593038     DOI: 10.1093/rpd/ncr218

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  18 in total

1.  Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.

Authors:  Fada Guan; Christopher Peeler; Lawrence Bronk; Changran Geng; Reza Taleei; Sharmalee Randeniya; Shuaiping Ge; Dragan Mirkovic; David Grosshans; Radhe Mohan; Uwe Titt
Journal:  Med Phys       Date:  2015-11       Impact factor: 4.071

2.  Extension of TOPAS for the simulation of proton radiation effects considering molecular and cellular endpoints.

Authors:  Lisa Polster; Jan Schuemann; Ilaria Rinaldi; Lucas Burigo; Aimee L McNamara; Robert D Stewart; Andrea Attili; David J Carlson; Tatsuhiko Sato; José Ramos Méndez; Bruce Faddegon; Joseph Perl; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-06-10       Impact factor: 3.609

3.  Using the Proton Energy Spectrum and Microdosimetry to Model Proton Relative Biological Effectiveness.

Authors:  Mark Newpower; Darshana Patel; Lawrence Bronk; Fada Guan; Pankaj Chaudhary; Stephen J McMahon; Kevin M Prise; Giuseppe Schettino; David R Grosshans; Radhe Mohan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-05       Impact factor: 7.038

Review 4.  Radiobiological issues in proton therapy.

Authors:  Radhe Mohan; Christopher R Peeler; Fada Guan; Lawrence Bronk; Wenhua Cao; David R Grosshans
Journal:  Acta Oncol       Date:  2017-08-22       Impact factor: 4.089

Review 5.  Modelling variable proton relative biological effectiveness for treatment planning.

Authors:  Aimee McNamara; Henning Willers; Harald Paganetti
Journal:  Br J Radiol       Date:  2019-11-18       Impact factor: 3.039

6.  A new formalism for modelling parameters α and β of the linear-quadratic model of cell survival for hadron therapy.

Authors:  Oleg N Vassiliev; David R Grosshans; Radhe Mohan
Journal:  Phys Med Biol       Date:  2017-10-03       Impact factor: 3.609

7.  Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.

Authors:  Christopher R Peeler; Dragan Mirkovic; Uwe Titt; Pierre Blanchard; Jillian R Gunther; Anita Mahajan; Radhe Mohan; David R Grosshans
Journal:  Radiother Oncol       Date:  2016-11-16       Impact factor: 6.280

8.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

9.  Modelling recurrence and second cancer risks induced by proton therapy.

Authors:  V S K Manem; A Dhawan
Journal:  Math Med Biol       Date:  2018-09-11       Impact factor: 1.854

10.  RBE Model-Based Biological Dose Optimization for Proton Radiobiology Studies.

Authors:  Fada Guan; Changran Geng; Duo Ma; Lawrence Bronk; Matthew Kerr; Yuting Li; Drake Gates; Benjamin Kroger; Narayan Sahoo; Uwe Titt; David Grosshans; Radhe Mohan
Journal:  Int J Part Ther       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.